GO Annotation
| Category | Term ID | Term description |
|---|---|---|
| Process | GO:0001573 | Ganglioside metabolic process |
| Process | GO:0006066 | Alcohol metabolic process |
| Process | GO:0006355 | Regulation of transcription, DNA-templated |
| Process | GO:0006357 | Regulation of transcription by RNA polymerase II |
| Process | GO:0006629 | Lipid metabolic process |
| Process | GO:0006643 | Membrane lipid metabolic process |
| Process | GO:0006644 | Phospholipid metabolic process |
| Process | GO:0006664 | Glycolipid metabolic process |
| Process | GO:0006665 | Sphingolipid metabolic process |
| Process | GO:0006670 | Sphingosine metabolic process |
| Process | GO:0006672 | Ceramide metabolic process |
| Process | GO:0006684 | Sphingomyelin metabolic process |
| Process | GO:0006687 | Glycosphingolipid metabolic process |
| Process | GO:0006793 | Phosphorus metabolic process |
| Process | GO:0006796 | Phosphate-containing compound metabolic process |
| Process | GO:0006807 | Nitrogen compound metabolic process |
| Process | GO:0006810 | Transport |
| Process | GO:0006869 | Lipid transport |
| Process | GO:0007272 | Ensheathment of neurons |
| Process | GO:0007275 | Multicellular organism development |
| Process | GO:0007399 | Nervous system development |
| Process | GO:0007417 | Central nervous system development |
| Process | GO:0007610 | Behavior |
| Process | GO:0007626 | Locomotory behavior |
| Process | GO:0008152 | Metabolic process |
| Process | GO:0008366 | Axon ensheathment |
| Process | GO:0008610 | Lipid biosynthetic process |
| Process | GO:0009058 | Biosynthetic process |
| Process | GO:0009653 | Anatomical structure morphogenesis |
| Process | GO:0009719 | Response to endogenous stimulus |
| Process | GO:0009725 | Response to hormone |
| Process | GO:0009889 | Regulation of biosynthetic process |
| Process | GO:0009890 | Negative regulation of biosynthetic process |
| Process | GO:0009891 | Positive regulation of biosynthetic process |
| Process | GO:0009892 | Negative regulation of metabolic process |
| Process | GO:0009893 | Positive regulation of metabolic process |
| Process | GO:0009894 | Regulation of catabolic process |
| Process | GO:0009896 | Positive regulation of catabolic process |
| Process | GO:0009987 | Cellular process |
| Process | GO:0010001 | Glial cell differentiation |
| Process | GO:0010033 | Response to organic substance |
| Process | GO:0010468 | Regulation of gene expression |
| Process | GO:0010556 | Regulation of macromolecule biosynthetic process |
| Process | GO:0010557 | Positive regulation of macromolecule biosynthetic process |
| Process | GO:0010559 | Regulation of glycoprotein biosynthetic process |
| Process | GO:0010560 | Positive regulation of glycoprotein biosynthetic process |
| Process | GO:0010563 | Negative regulation of phosphorus metabolic process |
| Process | GO:0010604 | Positive regulation of macromolecule metabolic process |
| Process | GO:0010872 | Regulation of cholesterol esterification |
| Process | GO:0010874 | Regulation of cholesterol efflux |
| Process | GO:0010876 | Lipid localization |
| Process | GO:0010927 | Cellular component assembly involved in morphogenesis |
| Process | GO:0014003 | Oligodendrocyte development |
| Process | GO:0014070 | Response to organic cyclic compound |
| Process | GO:0016043 | Cellular component organization |
| Process | GO:0019216 | Regulation of lipid metabolic process |
| Process | GO:0019218 | Regulation of steroid metabolic process |
| Process | GO:0019219 | Regulation of nucleobase-containing compound metabolic process |
| Process | GO:0019220 | Regulation of phosphate metabolic process |
| Process | GO:0019222 | Regulation of metabolic process |
| Process | GO:0019637 | Organophosphate metabolic process |
| Process | GO:0019725 | Cellular homeostasis |
| Process | GO:0019751 | Polyol metabolic process |
| Process | GO:0021782 | Glial cell development |
| Process | GO:0022008 | Neurogenesis |
| Process | GO:0022010 | Central nervous system myelination |
| Process | GO:0022607 | Cellular component assembly |
| Process | GO:0030100 | Regulation of endocytosis |
| Process | GO:0030148 | Sphingolipid biosynthetic process |
| Process | GO:0030154 | Cell differentiation |
| Process | GO:0030162 | Regulation of proteolysis |
| Process | GO:0031323 | Regulation of cellular metabolic process |
| Process | GO:0031324 | Negative regulation of cellular metabolic process |
| Process | GO:0031325 | Positive regulation of cellular metabolic process |
| Process | GO:0031326 | Regulation of cellular biosynthetic process |
| Process | GO:0031327 | Negative regulation of cellular biosynthetic process |
| Process | GO:0031328 | Positive regulation of cellular biosynthetic process |
| Process | GO:0031329 | Regulation of cellular catabolic process |
| Process | GO:0031331 | Positive regulation of cellular catabolic process |
| Process | GO:0031399 | Regulation of protein modification process |
| Process | GO:0032288 | Myelin assembly |
| Process | GO:0032289 | Central nervous system myelin formation |
| Process | GO:0032291 | Axon ensheathment in central nervous system |
| Process | GO:0032368 | Regulation of lipid transport |
| Process | GO:0032369 | Negative regulation of lipid transport |
| Process | GO:0032371 | Regulation of sterol transport |
| Process | GO:0032372 | Negative regulation of sterol transport |
| Process | GO:0032374 | Regulation of cholesterol transport |
| Process | GO:0032375 | Negative regulation of cholesterol transport |
| Process | GO:0032377 | Regulation of intracellular lipid transport |
| Process | GO:0032378 | Negative regulation of intracellular lipid transport |
| Process | GO:0032380 | Regulation of intracellular sterol transport |
| Process | GO:0032381 | Negative regulation of intracellular sterol transport |
| Process | GO:0032383 | Regulation of intracellular cholesterol transport |
| Process | GO:0032384 | Negative regulation of intracellular cholesterol transport |
| Process | GO:0032386 | Regulation of intracellular transport |
| Process | GO:0032387 | Negative regulation of intracellular transport |
| Process | GO:0032501 | Multicellular organismal process |
| Process | GO:0032502 | Developmental process |
| Process | GO:0032803 | Regulation of low-density lipoprotein particle receptor catabolic process |
| Process | GO:0032805 | Positive regulation of low-density lipoprotein particle receptor catabolic process |
| Process | GO:0032879 | Regulation of localization |
| Process | GO:0032880 | Regulation of protein localization |
| Process | GO:0032989 | Cellular component morphogenesis |
| Process | GO:0033036 | Macromolecule localization |
| Process | GO:0033993 | Response to lipid |
| Process | GO:0034204 | Lipid translocation |
| Process | GO:0034248 | Regulation of cellular amide metabolic process |
| Process | GO:0034250 | Positive regulation of cellular amide metabolic process |
| Process | GO:0034311 | Diol metabolic process |
| Process | GO:0034312 | Diol biosynthetic process |
| Process | GO:0034641 | Cellular nitrogen compound metabolic process |
| Process | GO:0035627 | Ceramide transport |
| Process | GO:0036314 | Response to sterol |
| Process | GO:0042063 | Gliogenesis |
| Process | GO:0042176 | Regulation of protein catabolic process |
| Process | GO:0042221 | Response to chemical |
| Process | GO:0042552 | Myelination |
| Process | GO:0042592 | Homeostatic process |
| Process | GO:0042632 | Cholesterol homeostasis |
| Process | GO:0042886 | Amide transport |
| Process | GO:0042984 | Regulation of amyloid precursor protein biosynthetic process |
| Process | GO:0042986 | Positive regulation of amyloid precursor protein biosynthetic process |
| Process | GO:0043603 | Cellular amide metabolic process |
| Process | GO:0044085 | Cellular component biogenesis |
| Process | GO:0044087 | Regulation of cellular component biogenesis |
| Process | GO:0044092 | Negative regulation of molecular function |
| Process | GO:0044237 | Cellular metabolic process |
| Process | GO:0044238 | Primary metabolic process |
| Process | GO:0044249 | Cellular biosynthetic process |
| Process | GO:0044255 | Cellular lipid metabolic process |
| Process | GO:0044271 | Cellular nitrogen compound biosynthetic process |
| Process | GO:0044281 | Small molecule metabolic process |
| Process | GO:0044283 | Small molecule biosynthetic process |
| Process | GO:0045732 | Positive regulation of protein catabolic process |
| Process | GO:0045806 | Negative regulation of endocytosis |
| Process | GO:0045833 | Negative regulation of lipid metabolic process |
| Process | GO:0045936 | Negative regulation of phosphate metabolic process |
| Process | GO:0045939 | Negative regulation of steroid metabolic process |
| Process | GO:0046165 | Alcohol biosynthetic process |
| Process | GO:0046173 | Polyol biosynthetic process |
| Process | GO:0046467 | Membrane lipid biosynthetic process |
| Process | GO:0046512 | Sphingosine biosynthetic process |
| Process | GO:0046519 | Sphingoid metabolic process |
| Process | GO:0046520 | Sphingoid biosynthetic process |
| Process | GO:0046890 | Regulation of lipid biosynthetic process |
| Process | GO:0048259 | Regulation of receptor-mediated endocytosis |
| Process | GO:0048261 | Negative regulation of receptor-mediated endocytosis |
| Process | GO:0048468 | Cell development |
| Process | GO:0048518 | Positive regulation of biological process |
| Process | GO:0048519 | Negative regulation of biological process |
| Process | GO:0048522 | Positive regulation of cellular process |
| Process | GO:0048523 | Negative regulation of cellular process |
| Process | GO:0048545 | Response to steroid hormone |
| Process | GO:0048646 | Anatomical structure formation involved in morphogenesis |
| Process | GO:0048709 | Oligodendrocyte differentiation |
| Process | GO:0048731 | System development |
| Process | GO:0048856 | Anatomical structure development |
| Process | GO:0048869 | Cellular developmental process |
| Process | GO:0048878 | Chemical homeostasis |
| Process | GO:0050789 | Regulation of biological process |
| Process | GO:0050790 | Regulation of catalytic activity |
| Process | GO:0050794 | Regulation of cellular process |
| Process | GO:0050896 | Response to stimulus |
| Process | GO:0051049 | Regulation of transport |
| Process | GO:0051051 | Negative regulation of transport |
| Process | GO:0051055 | Negative regulation of lipid biosynthetic process |
| Process | GO:0051128 | Regulation of cellular component organization |
| Process | GO:0051129 | Negative regulation of cellular component organization |
| Process | GO:0051171 | Regulation of nitrogen compound metabolic process |
| Process | GO:0051172 | Negative regulation of nitrogen compound metabolic process |
| Process | GO:0051173 | Positive regulation of nitrogen compound metabolic process |
| Process | GO:0051174 | Regulation of phosphorus metabolic process |
| Process | GO:0051179 | Localization |
| Process | GO:0051234 | Establishment of localization |
| Process | GO:0051246 | Regulation of protein metabolic process |
| Process | GO:0051247 | Positive regulation of protein metabolic process |
| Process | GO:0051252 | Regulation of RNA metabolic process |
| Process | GO:0051336 | Regulation of hydrolase activity |
| Process | GO:0052547 | Regulation of peptidase activity |
| Process | GO:0052548 | Regulation of endopeptidase activity |
| Process | GO:0055082 | Cellular chemical homeostasis |
| Process | GO:0055085 | Transmembrane transport |
| Process | GO:0055088 | Lipid homeostasis |
| Process | GO:0055092 | Sterol homeostasis |
| Process | GO:0060049 | Regulation of protein glycosylation |
| Process | GO:0060255 | Regulation of macromolecule metabolic process |
| Process | GO:0060341 | Regulation of cellular localization |
| Process | GO:0060627 | Regulation of vesicle-mediated transport |
| Process | GO:0061024 | Membrane organization |
| Process | GO:0065007 | Biological regulation |
| Process | GO:0065008 | Regulation of biological quality |
| Process | GO:0065009 | Regulation of molecular function |
| Process | GO:0070723 | Response to cholesterol |
| Process | GO:0071071 | Regulation of phospholipid biosynthetic process |
| Process | GO:0071072 | Negative regulation of phospholipid biosynthetic process |
| Process | GO:0071702 | Organic substance transport |
| Process | GO:0071704 | Organic substance metabolic process |
| Process | GO:0071705 | Nitrogen compound transport |
| Process | GO:0071840 | Cellular component organization or biogenesis |
| Process | GO:0080090 | Regulation of primary metabolic process |
| Process | GO:0090153 | Regulation of sphingolipid biosynthetic process |
| Process | GO:0090155 | Negative regulation of sphingolipid biosynthetic process |
| Process | GO:0090156 | Cellular sphingolipid homeostasis |
| Process | GO:0090370 | Negative regulation of cholesterol efflux |
| Process | GO:0097035 | Regulation of membrane lipid distribution |
| Process | GO:0097305 | Response to alcohol |
| Process | GO:0099039 | Sphingolipid translocation |
| Process | GO:0099040 | Ceramide translocation |
| Process | GO:0150110 | Negative regulation of cholesterol esterification |
| Process | GO:1901135 | Carbohydrate derivative metabolic process |
| Process | GO:1901564 | Organonitrogen compound metabolic process |
| Process | GO:1901566 | Organonitrogen compound biosynthetic process |
| Process | GO:1901576 | Organic substance biosynthetic process |
| Process | GO:1901615 | Organic hydroxy compound metabolic process |
| Process | GO:1901617 | Organic hydroxy compound biosynthetic process |
| Process | GO:1901700 | Response to oxygen-containing compound |
| Process | GO:1901873 | Regulation of post-translational protein modification |
| Process | GO:1902003 | Regulation of amyloid-beta formation |
| Process | GO:1902004 | Positive regulation of amyloid-beta formation |
| Process | GO:1902991 | Regulation of amyloid precursor protein catabolic process |
| Process | GO:1902993 | Positive regulation of amyloid precursor protein catabolic process |
| Process | GO:1903018 | Regulation of glycoprotein metabolic process |
| Process | GO:1903020 | Positive regulation of glycoprotein metabolic process |
| Process | GO:1903506 | Regulation of nucleic acid-templated transcription |
| Process | GO:1903509 | Liposaccharide metabolic process |
| Process | GO:1903725 | Regulation of phospholipid metabolic process |
| Process | GO:1903726 | Negative regulation of phospholipid metabolic process |
| Process | GO:1904375 | Regulation of protein localization to cell periphery |
| Process | GO:1905038 | Regulation of membrane lipid metabolic process |
| Process | GO:1905598 | Negative regulation of low-density lipoprotein receptor activity |
| Process | GO:1905600 | Regulation of receptor-mediated endocytosis involved in cholesterol transport |
| Process | GO:1905601 | Negative regulation of receptor-mediated endocytosis involved in cholesterol transport |
| Process | GO:1905952 | Regulation of lipid localization |
| Process | GO:1905953 | Negative regulation of lipid localization |
| Process | GO:2000008 | Regulation of protein localization to cell surface |
| Process | GO:2000112 | Regulation of cellular macromolecule biosynthetic process |
| Process | GO:2000644 | Regulation of receptor catabolic process |
| Process | GO:2000646 | Positive regulation of receptor catabolic process |
| Process | GO:2001141 | Regulation of RNA biosynthetic process |
| Component | GO:0000323 | Lytic vacuole |
| Component | GO:0005622 | Intracellular anatomical structure |
| Component | GO:0005737 | Cytoplasm |
| Component | GO:0005764 | Lysosome |
| Component | GO:0005765 | Lysosomal membrane |
| Component | GO:0005768 | Endosome |
| Component | GO:0005773 | Vacuole |
| Component | GO:0005774 | Vacuolar membrane |
| Component | GO:0005815 | Microtubule organizing center |
| Component | GO:0005856 | Cytoskeleton |
| Component | GO:0005886 | Plasma membrane |
| Component | GO:0010008 | Endosome membrane |
| Component | GO:0012505 | Endomembrane system |
| Component | GO:0012506 | Vesicle membrane |
| Component | GO:0015630 | Microtubule cytoskeleton |
| Component | GO:0016020 | Membrane |
| Component | GO:0016021 | Integral component of membrane |
| Component | GO:0030659 | Cytoplasmic vesicle membrane |
| Component | GO:0031090 | Organelle membrane |
| Component | GO:0031224 | Intrinsic component of membrane |
| Component | GO:0031410 | Cytoplasmic vesicle |
| Component | GO:0031982 | Vesicle |
| Component | GO:0043226 | Organelle |
| Component | GO:0043227 | Membrane-bounded organelle |
| Component | GO:0043228 | Non-membrane-bounded organelle |
| Component | GO:0043229 | Intracellular organelle |
| Component | GO:0043231 | Intracellular membrane-bounded organelle |
| Component | GO:0043232 | Intracellular non-membrane-bounded organelle |
| Component | GO:0071944 | Cell periphery |
| Component | GO:0097708 | Intracellular vesicle |
| Component | GO:0098588 | Bounding membrane of organelle |
| Component | GO:0098852 | Lytic vacuole membrane |
| Component | GO:0110165 | Cellular anatomical entity |
| Function | GO:0000166 | Nucleotide binding |
| Function | GO:0005215 | Transporter activity |
| Function | GO:0005319 | Lipid transporter activity |
| Function | GO:0005488 | Binding |
| Function | GO:0005524 | ATP binding |
| Function | GO:0015399 | Primary active transmembrane transporter activity |
| Function | GO:0017076 | Purine nucleotide binding |
| Function | GO:0022804 | Active transmembrane transporter activity |
| Function | GO:0022857 | Transmembrane transporter activity |
| Function | GO:0030234 | Enzyme regulator activity |
| Function | GO:0030554 | Adenyl nucleotide binding |
| Function | GO:0032553 | Ribonucleotide binding |
| Function | GO:0032555 | Purine ribonucleotide binding |
| Function | GO:0032559 | Adenyl ribonucleotide binding |
| Function | GO:0035639 | Purine ribonucleoside triphosphate binding |
| Function | GO:0036094 | Small molecule binding |
| Function | GO:0042626 | ATPase-coupled transmembrane transporter activity |
| Function | GO:0043167 | Ion binding |
| Function | GO:0043168 | Anion binding |
| Function | GO:0046623 | Sphingolipid floppase activity |
| Function | GO:0046624 | Sphingolipid transporter activity |
| Function | GO:0061134 | Peptidase regulator activity |
| Function | GO:0061135 | Endopeptidase regulator activity |
| Function | GO:0097159 | Organic cyclic compound binding |
| Function | GO:0097367 | Carbohydrate derivative binding |
| Function | GO:0098772 | Molecular function regulator activity |
| Function | GO:0099038 | Ceramide floppase activity |
| Function | GO:0140303 | Intramembrane lipid transporter activity |
| Function | GO:0140326 | ATPase-coupled intramembrane lipid transporter activity |
| Function | GO:0140328 | Floppase activity |
| Function | GO:0140359 | ABC-type transporter activity |
| Function | GO:0140657 | ATP-dependent activity |
| Function | GO:1901265 | Nucleoside phosphate binding |
| Function | GO:1901363 | Heterocyclic compound binding |
Pathway annotation
| Category | Term ID | Term description |
|---|---|---|
| RCTM | RNO-1369062 | ABC transporters in lipid homeostasis |
| RCTM | RNO-382551 | Transport of small molecules |
| RCTM | RNO-382556 | ABC-family proteins mediated transport |
Expression profile of Abca2 in omics data
| ID | GSE100499 |
| Title | Exploring acupuncture mechanism in preconditioning of IRI |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM2685201 | MX1 | tissue: Myocardium gender: male | 11.892025 |
| GSM2685202 | MX2 | tissue: Myocardium gender: female | 11.559549 |
| GSM2685203 | MX3 | tissue: Myocardium gender: female | 12.038879 |
| GSM2685204 | MX4 | tissue: Myocardium gender: male | 11.947858 |
| GSM2685205 | DZ1 | tissue: Myocardium gender: male | 11.767425 |
| GSM2685206 | DZ2 | tissue: Myocardium gender: male | 11.681115 |
| GSM2685207 | DZ3 | tissue: Myocardium gender: female | 11.770165 |
| GSM2685208 | DZ4 | tissue: Myocardium gender: female | 12.110332 |
| GSM2685209 | JJ1 | tissue: Myocardium gender: male | 11.38171 |
| GSM2685210 | JJ2 | tissue: Myocardium gender: female | 11.433975 |
| GSM2685211 | JJ3 | tissue: Myocardium gender: female | 11.634816 |
| GSM2685212 | JJ4 | tissue: Myocardium gender: male | 11.981397 |
| GSM2685213 | NG1 | tissue: Myocardium gender: male | 11.813179 |
| GSM2685214 | NG2 | tissue: Myocardium gender: female | 11.742881 |
| GSM2685215 | NG3 | tissue: Myocardium gender: male | 11.838661 |
| GSM2685216 | NG4 | tissue: Myocardium gender: female | 11.933057 |
| GSM2685217 | YL1 | tissue: Myocardium gender: male | 11.830409 |
| GSM2685218 | YL2 | tissue: Myocardium gender: male | 11.915188 |
| GSM2685219 | YL3 | tissue: Myocardium gender: female | 11.846406 |
| GSM2685220 | YL4 | tissue: Myocardium gender: female | 12.288772 |
| GSM2685221 | QC1 | tissue: Myocardium gender: male | 12.094492 |
| GSM2685222 | QC2 | tissue: Myocardium gender: male | 11.94831 |
| GSM2685223 | QC3 | tissue: Myocardium gender: female | 11.925195 |
| GSM2685224 | QC4 | tissue: Myocardium gender: female | 12.299943 |
| ID | GSE136833 |
| Title | Effects of lidocaine on the expression of rat spinal cord |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4058984 | Control_1 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 8.780708926 |
| GSM4058985 | Control_2 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 8.815022946 |
| GSM4058986 | Control_3 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 8.851659245 |
| GSM4058987 | Lidocaine_1 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 8.49832493 |
| GSM4058988 | Lidocaine_2 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 8.17233109 |
| GSM4058989 | Lidocaine_3 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 8.291756647 |
| ID | GSE138454 |
| Title | Impact of inflammation on hepatic subcellular energetics in anesthetized rats |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4108997 | Sample 1 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 443.0 |
| GSM4108998 | Sample 2 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 268.0 |
| GSM4108999 | Sample 3 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 342.0 |
| GSM4109000 | Sample 4 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 339.0 |
| GSM4109001 | Sample 5 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 577.0 |
| GSM4109002 | Sample 6 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 616.0 |
| GSM4109003 | Sample 7 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 669.0 |
| GSM4109004 | Sample 8 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 1559.0 |
| GSM4109005 | Sample9 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 481.0 |
| GSM4109006 | Sample10 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 1069.0 |
| GSM4109007 | Sample11 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 363.0 |
| GSM4109008 | Sample12 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 743.0 |
| GSM4109009 | Sample13 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 472.0 |
| GSM4109010 | Sample14 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 511.0 |
| GSM4109011 | Sample 15 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 525.0 |
| GSM4109012 | Sample16 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 647.0 |
| ID | GSE139220 |
| Title | Expression data from sevoflurane anesthesia treated rat |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4134285 | Brain_Control_rep1 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 9.511944 |
| GSM4134286 | Brain_Control_rep2 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 9.574456 |
| GSM4134287 | Brain_Control_rep3 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 9.647139 |
| GSM4134288 | Brain_Sevoflurane_rep1 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 9.693776 |
| GSM4134289 | Brain_Sevoflurane_rep2 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 9.69118 |
| GSM4134290 | Brain_Sevoflurane_rep3 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 9.585307 |
| ID | GSE143895 |
| Title | GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4276356 | dhsc01 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 132.632 |
| GSM4276357 | dhsc03 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 96.695 |
| GSM4276358 | dhsc05 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 134.402 |
| GSM4276359 | dhsc13 | strain: Sprague Dawley tissue: DHSC treatment: SHAM | 134.771 |
| GSM4276360 | dhsc15 | strain: Sprague Dawley tissue: DHSC treatment: SHAM | 131.993 |
| ID | GSE157924 |
| Title | Regulation of acupuncture on genes in brain stem |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4780973 | Rattus_JSSZ(Sham) | tissue: Rattus brainstem of modeling treatment: Sham | 10.43425604 |
| GSM4780974 | Rattus_JXZ(Hand Acu) | tissue: Rattus brainstem of modeling treatment: Hand Acu | 10.35912511 |
| GSM4780975 | Rattus_MXZ(TBI) | tissue: Rattus brainstem of modeling treatment: TBI | 10.41836505 |
| ID | GSE1779 |
| Title | Effect of Isoflurane and LTM on basolateral amygdala |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM30790 | baseline control 01 | male, 275-300g | 670.5 |
| GSM30791 | baseline control 02 | male, 275-300g | 689.2 |
| GSM30792 | baseline control 03 | male, 275-300g | 565.6 |
| GSM30793 | baseline control 04 | male, 275-300g | 664.9 |
| GSM30794 | baseline control 05 | male, 275-300g | 686.0 |
| GSM30795 | baseline control 06 | male, 275-300g | 445.0 |
| GSM30796 | baseline control 07 | male, 275-300g | 518.0 |
| GSM30797 | baseline control 08 | male, 275-300g | 589.3 |
| GSM30798 | baseline control 09 | male, 275-300g | 739.0 |
| GSM30799 | pain 01 | 742.6 | |
| GSM30800 | pain 02 | 588.0 | |
| GSM30801 | pain 03 | 794.8 | |
| GSM30802 | pain 04 | 583.0 | |
| GSM30803 | pain 05 | 665.9 | |
| GSM30804 | FC 01 | 713.8 | |
| GSM30805 | FC 02 | 763.3 | |
| GSM30806 | FC 03 | 659.8 | |
| GSM30807 | FC 04 | 715.7 | |
| GSM30808 | FC 05 | 769.7 | |
| GSM30809 | IFC 01 | 735.2 | |
| GSM30810 | IFC 02 | 637.6 | |
| GSM30811 | IFC 03 | 834.5 | |
| GSM30812 | IFC 04 | 622.4 | |
| GSM30813 | IFC 05 | 682.6 | |
| GSM99800 | isoflurane 01 | male, 275-300g | 491.2 |
| GSM99801 | isoflurane 02 | male, 275-300g | 742.1 |
| GSM99802 | isoflurane 03 | male, 275-300g | 524.1 |
| GSM99803 | isoflurane 04 | male, 275-300g | 620.9 |
| GSM99804 | isoflurane 05 | male, 275-300g | 822.7 |
| ID | GSE190472 |
| Title | Study on VEGF regulation mechanism of acupuncture improving endometrial receptivity in IVF-ET |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM5724271 | model 21 | Sex: female tissue: Uterine tissue condition: model | 44.2088 |
| GSM5724272 | model 22 | Sex: female tissue: Uterine tissue condition: model | 45.2052 |
| GSM5724273 | model 23 | Sex: female tissue: Uterine tissue condition: model | 41.1159 |
| GSM5724274 | treatment31 | Sex: female tissue: Uterine tissue condition: treatment | 35.7056 |
| GSM5724275 | treatment32 | Sex: female tissue: Uterine tissue condition: treatment | 35.0697 |
| GSM5724276 | treatment33 | Sex: female tissue: Uterine tissue condition: treatment | 32.5113 |
| GSM5724277 | control 41 | Sex: female tissue: Uterine tissue condition: control | 35.0239 |
| GSM5724278 | control 42 | Sex: female tissue: Uterine tissue condition: control | 37.6992 |
| GSM5724279 | control 43 | Sex: female tissue: Uterine tissue condition: control | 48.1142 |
| ID | GSE192399 |
| Title | Gene expression of brain regions activated by sevoflurane and propofol |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM5746332 | LHb, Sevoflurane, 60mins | brain region: the lateral habenula (LHb) treatment: Sevoflurane | 13.009 |
| GSM5746333 | LHb, O2, 60mins | brain region: the lateral habenula (LHb) treatment: O2 | 13.3904 |
| GSM5746334 | MHb, Sevoflurane, 60mins | brain region: the medial habenula (MHb) treatment: Sevoflurane | 12.3879 |
| GSM5746335 | MHb, O2, 60mins | brain region: the medial habenula (MHb) treatment: O2 | 12.1382 |
| GSM5746336 | Sol, Sevoflurane, 60mins | brain region: the solitary nucleus (Sol) treatment: Sevoflurane | 11.9416 |
| GSM5746337 | Sol, O2, 60mins | brain region: the solitary nucleus (Sol) treatment: O2 | 12.3019 |
| GSM5746338 | Mve, Sevoflurane, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Sevoflurane | 13.6395 |
| GSM5746339 | Mve, O2, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: O2 | 13.4313 |
| GSM5746340 | LHb, Propofol, 60mins | brain region: the lateral habenula (LHb) treatment: Propofol | 12.5946 |
| GSM5746341 | LHb, Intralipos, 60mins | brain region: the lateral habenula (LHb) treatment: Intralipos | 12.5489 |
| GSM5746342 | MHb, Propofol, 60mins | brain region: the medial habenula (MHb) treatment: Propofol | 12.0233 |
| GSM5746343 | MHb, Intralipos, 60mins | brain region: the medial habenula (MHb) treatment: Intralipos | 11.4781 |
| GSM5746344 | Sol, Propofol, 60mins | brain region: the solitary nucleus (Sol) treatment: Propofol | 11.8751 |
| GSM5746345 | Sol, Intralipos, 60mins | brain region: the solitary nucleus (Sol) treatment: Intralipos | 11.1762 |
| GSM5746346 | MVe, Propofol, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Propofol | 13.1925 |
| GSM5746347 | MVe, Intralipos, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Intralipos | 13.2267 |
| ID | GSE205202 |
| Title | Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [rat] |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM6208507 | Rat_Baseline_0h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 | 8.509427 |
| GSM6208508 | Rat_Baseline_0h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 | 8.805109 |
| GSM6208509 | Rat_Baseline_0h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 | 8.566706 |
| GSM6208510 | Rat_Baseline_0h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 | 8.669084 |
| GSM6208511 | Rat_Baseline_0h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 | 8.426282 |
| GSM6208512 | Rat_Vehicle_03h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 8.712416 |
| GSM6208513 | Rat_Vehicle_03h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 8.80847 |
| GSM6208514 | Rat_Vehicle_03h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 8.751972 |
| GSM6208515 | Rat_Vehicle_03h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 8.697083 |
| GSM6208516 | Rat_Vehicle_03h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 8.811 |
| GSM6208517 | Rat_Vehicle_06h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 8.817037 |
| GSM6208518 | Rat_Vehicle_06h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 8.669084 |
| GSM6208519 | Rat_Vehicle_06h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 8.765494 |
| GSM6208520 | Rat_Vehicle_06h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 8.732218 |
| GSM6208521 | Rat_Vehicle_06h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 8.714853 |
| GSM6208522 | Rat_Vehicle_09h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 8.718571 |
| GSM6208523 | Rat_Vehicle_09h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 8.704229 |
| GSM6208524 | Rat_Vehicle_09h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 8.828899 |
| GSM6208525 | Rat_Vehicle_09h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 8.698454 |
| GSM6208526 | Rat_Vehicle_09h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 8.734389 |
| GSM6208527 | Rat_Vehicle_24h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 8.510431 |
| GSM6208528 | Rat_Vehicle_24h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 8.606401 |
| GSM6208529 | Rat_Vehicle_24h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 8.676093 |
| GSM6208530 | Rat_Vehicle_24h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 8.698972 |
| GSM6208531 | Rat_Vehicle_24h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 8.813335 |
| GSM6208532 | Rat_APAP_03h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 8.460717 |
| GSM6208533 | Rat_APAP_03h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 8.586651 |
| GSM6208534 | Rat_APAP_03h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 8.625865 |
| GSM6208535 | Rat_APAP_03h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 8.299894 |
| GSM6208536 | Rat_APAP_03h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 8.529724 |
| GSM6208537 | Rat_APAP_06h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 8.207056 |
| GSM6208538 | Rat_APAP_06h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 8.581539 |
| GSM6208539 | Rat_APAP_06h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 8.477287 |
| GSM6208540 | Rat_APAP_06h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 8.390861 |
| GSM6208541 | Rat_APAP_06h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 8.377236 |
| GSM6208542 | Rat_APAP_09h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 8.488823 |
| GSM6208543 | Rat_APAP_09h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 9.059484 |
| GSM6208544 | Rat_APAP_09h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 8.861433 |
| GSM6208545 | Rat_APAP_09h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 8.61518 |
| GSM6208546 | Rat_APAP_09h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 8.474852 |
| GSM6208547 | Rat_APAP_24h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 8.773097 |
| GSM6208548 | Rat_APAP_24h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 8.794903 |
| GSM6208549 | Rat_APAP_24h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 8.516757 |
| GSM6208550 | Rat_APAP_24h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 8.707174 |
| GSM6208551 | Rat_APAP_24h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 8.683494 |
| ID | GSE21258 |
| Title | Transcript Profiling of Spinal Dorsal Horn in Response to Electroacupuncture on Rats at 1h |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM531353 | 2Hz_HR_1h_DH1 rat | time point: 1h strain: Sprague-Dawley tissue type: spinal dorsal horn frequency: 2Hz group: high responder (HR) rats;strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation. | 0.0 |
| GSM531354 | 2Hz_HR_1h_DH2 rat | time point: 1h strain: Sprague-Dawley tissue type: spinal dorsal horn frequency: 2Hz group: high responder (HR) rats;strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation. | 0.0 |
| GSM531355 | 2Hz_HR_1h_DH3 rat | time point: 1h strain: Sprague-Dawley tissue type: spinal dorsal horn frequency: 2Hz group: high responder (HR) rats;strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation. | -1.673 |
| GSM531356 | 2Hz_HR_1h_DH4 rat | time point: 1h strain: Sprague-Dawley tissue type: spinal dorsal horn frequency: 2Hz group: high responder (HR) rats;strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation. | 0.0 |
| GSM531357 | 2Hz_HR_1h_DH5 rat | time point: 1h strain: Sprague-Dawley tissue type: spinal dorsal horn frequency: 2Hz group: high responder (HR) rats;strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation. | 0.0 |
| GSM531358 | 2Hz_LR_1h_DH1 rat | time point: 1h strain: Sprague-Dawley tissue type: spinal dorsal horn frequency: 2Hz group: low responder (LR) rats;strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation. | 0.0 |
| GSM531359 | 2Hz_LR_1h_DH2 rat | time point: 1h strain: Sprague-Dawley tissue type: spinal dorsal horn frequency: 2Hz group: low responder (LR) rats;strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation. | 0.0 |
| GSM531360 | 2Hz_LR_1h_DH3 rat | time point: 1h strain: Sprague-Dawley tissue type: spinal dorsal horn frequency: 2Hz group: low responder (LR) rats;strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation. | 0.0 |
| GSM531361 | 2Hz_LR_1h_DH4 rat | time point: 1h strain: Sprague-Dawley tissue type: spinal dorsal horn frequency: 2Hz group: low responder (LR) rats;strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation. | 0.0 |
| GSM531362 | 100Hz_HR_1h_DH1 rat | time point: 1h strain: Sprague-Dawley tissue type: spinal dorsal horn frequency: 100Hz group: high responder (HR) rats;strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation. | -1.008 |
| GSM531363 | 100Hz_HR_1h_DH2 rat | time point: 1h strain: Sprague-Dawley tissue type: spinal dorsal horn frequency: 100Hz group: high responder (HR) rats;strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation. | -0.021 |
| GSM531364 | 100Hz_HR_1h_DH3 rat | time point: 1h strain: Sprague-Dawley tissue type: spinal dorsal horn frequency: 100Hz group: high responder (HR) rats;strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation. | -2.182 |
| GSM531365 | 100Hz_HR_1h_DH4 rat | time point: 1h strain: Sprague-Dawley tissue type: spinal dorsal horn frequency: 100Hz group: high responder (HR) rats;strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation. | -1.326 |
| GSM531366 | 100Hz_HR_1h_DH5 rat | time point: 1h strain: Sprague-Dawley tissue type: spinal dorsal horn frequency: 100Hz group: high responder (HR) rats;strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation. | 0.0 |
| GSM531367 | 100Hz_LR_1h_DH1 rat | time point: 1h;strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation. strain: Sprague-Dawley tissue type: spinal dorsal horn frequency: 100Hz group: low responder (LR) rats | 0.236 |
| GSM531368 | 100Hz_LR_1h_DH2 rat | time point: 1h strain: Sprague-Dawley tissue type: spinal dorsal horn frequency: 100Hz group: low responder (LR) rats;strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation. | 0.584 |
| GSM531369 | 100Hz_LR_1h_DH3 rat | time point: 1h strain: Sprague-Dawley tissue type: spinal dorsal horn frequency: 100Hz group: low responder (LR) rats;strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation. | -0.509 |
| GSM531370 | 100Hz_LR_1h_DH4 rat | time point: 1h strain: Sprague-Dawley tissue type: spinal dorsal horn frequency: 100Hz group: low responder (LR) rats;strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation. | -0.901 |
| GSM531371 | 100Hz_LR_1h_DH5 rat | time point: 1h strain: Sprague-Dawley tissue type: spinal dorsal horn frequency: 100Hz group: low responder (LR) rats;strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation. | -0.929 |
| ID | GSE21733 |
| Title | Transcript Profiling of Spinal Dorsal Horn in Response to Electroacupuncture on Rats at 24h |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM542196 | 2Hz_HR_24h_DH1 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 2Hz group: high responder (HR) rats tissue type: dorsal horn (DH); strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | -0.934038354 |
| GSM542197 | 2Hz_HR_24h_DH2 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 2Hz group: high responder (HR) rats tissue type: dorsal horn (DH); strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | -0.950526188 |
| GSM542198 | 2Hz_HR_24h_DH3 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 2Hz group: high responder (HR) rats tissue type: dorsal horn (DH); strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | 0.05751679 |
| GSM542199 | 2Hz_HR_24h_DH4 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 2Hz group: high responder (HR) rats tissue type: dorsal horn (DH); strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | -0.520732195 |
| GSM542200 | 2Hz_HR_24h_DH5 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 2Hz group: high responder (HR) rats tissue type: dorsal horn (DH);strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | -1.604718279 |
| GSM542201 | 2Hz_LR_24h_DH1 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 2Hz group: low responder (LR) rats tissue type: dorsal horn (DH);strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | -1.60567508 |
| GSM542202 | 2Hz_LR_24h_DH2 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 2Hz group: low responder (LR) rats tissue type: dorsal horn (DH);strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | -0.52102968 |
| GSM542203 | 2Hz_LR_24h_DH3 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 2Hz group: low responder (LR) rats tissue type: dorsal horn (DH);strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | -0.468241602 |
| GSM542204 | 2Hz_LR_24h_DH4 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 2Hz group: low responder (LR) rats tissue type: dorsal horn (DH);strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | -0.316773249 |
| GSM542205 | 2Hz_LR_24h_DH5 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 2Hz group: low responder (LR) rats tissue type: dorsal horn (DH);strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | -0.772987395 |
| GSM542206 | 100Hz_HR_24h_DH1 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 100Hz group: high responder (HR) rats tissue type: dorsal horn (DH);strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | -1.421403086 |
| GSM542207 | 100Hz_HR_24h_DH2 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 100Hz group: high responder (HR) rats tissue type: dorsal horn (DH);strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | -1.919814626 |
| GSM542208 | 100Hz_HR_24h_DH3 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 100Hz group: high responder (HR) rats tissue type: dorsal horn (DH);strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | -0.426344707 |
| GSM542209 | 100Hz_HR_24h_DH4 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 100Hz group: high responder (HR) rats tissue type: dorsal horn (DH);strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | 0.251835661 |
| GSM542210 | 100Hz_HR_24h_DH5 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 100Hz group: high responder (HR) rats tissue type: dorsal horn (DH);strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | -0.519858281 |
| GSM542211 | 100Hz_LR_24h_DH1 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 100Hz group: low responder (LR) rats tissue type: dorsal horn (DH);strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | -0.20195324 |
| GSM542212 | 100Hz_LR_24h_DH2 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 100Hz group: low responder (LR) rats tissue type: dorsal horn (DH);strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | -0.417274977 |
| GSM542213 | 100Hz_LR_24h_DH3 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 100Hz group: low responder (LR) rats tissue type: dorsal horn (DH);strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | -0.638468234 |
| GSM542214 | 100Hz_LR_24h_DH4 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 100Hz group: low responder (LR) rats tissue type: dorsal horn (DH);strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | -0.217108792 |
| GSM542215 | 100Hz_LR_24h_DH5 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 100Hz group: low responder (LR) rats tissue type: dorsal horn (DH);strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | -0.96025091 |
| ID | GSE232804 |
| Title | EGR3 regulates opioid-related nociception and motivation in male rats |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM7383519 | ww01_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 2007.0 |
| GSM7383520 | ww02_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 2220.0 |
| GSM7383521 | ww03_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 2568.0 |
| GSM7383522 | ww05_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 2721.0 |
| GSM7383523 | ww06_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 2617.0 |
| GSM7383524 | ww07_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 2960.0 |
| GSM7383525 | ww08_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 3152.0 |
| GSM7383526 | ww10_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 2877.0 |
| GSM7383527 | ww12_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 2612.0 |
| GSM7383528 | ww13_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 3958.0 |
| GSM7383529 | ww14_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 2131.0 |
| GSM7383530 | ww15_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 2730.0 |
| GSM7383531 | ww16_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 2852.0 |
| GSM7383532 | ww17_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 3639.0 |
| GSM7383533 | ww18_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 3323.0 |
| GSM7383534 | ww20_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 3128.0 |
| GSM7383535 | ww21_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 2758.0 |
| GSM7383536 | ww22_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 2285.0 |
| GSM7383537 | ww23_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 2495.0 |
| GSM7383538 | ww24_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 2544.0 |
| GSM7383539 | ww26_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 2741.0 |
| GSM7383540 | ww27_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 3214.0 |
| GSM7383541 | ww28_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 3518.0 |
| GSM7383542 | ww30_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 3048.0 |
| GSM7383543 | ww31_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 3003.0 |
| GSM7383544 | ww32_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 2899.0 |
| GSM7383545 | ww34_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 3340.0 |
| GSM7383546 | ww35_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 2513.0 |
| GSM7383547 | ww36_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 3085.0 |
| GSM7383548 | ww37_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 2778.0 |
| GSM7383549 | ww38_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 3556.0 |
| GSM7383550 | www09_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 3411.0 |
| GSM7383551 | www19_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 3244.0 |
| GSM7383552 | www29_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 2892.0 |
| GSM7383553 | www33_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 2717.0 |
| GSM7383554 | www39_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 3169.0 |
| ID | GSE244436 |
| Title | Similarity and dissimilarity in alteration of gene expression profile associated with inhalational anesthesia between sevoflurane and desflurane |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM7816143 | Liver, Control for SevoAnes | tissue: liver genotype: wild type treatment: Control for SevoAnes | 14.339686 |
| GSM7816144 | Liver, Anesthetized with sevoflurane for 6 h | tissue: liver genotype: wild type treatment: Anesthetized with sevoflurane for 6 h | 14.278239 |
| GSM7816145 | Liver, Control for DesAnes | tissue: liver genotype: wild type treatment: Control for DesAnes | 14.531508 |
| GSM7816146 | Liver, Anesthetized with desflurane for 6 h | tissue: liver genotype: wild type treatment: Anesthetized with desflurane for 6 h | 14.714034 |
| ID | GSE2982 |
| Title | Effect of inhaled anesthetic to cultured cortical neurons |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM61779 | Cell Culture Exposure (control1) | Cy3 label;Cy5; | -0.166 |
| GSM61796 | Cell Culture Exposure (control2) | Cy3; Cy5 | -0.194 |
| GSM61797 | Cell Culture Exposure (control3) | Cy3; Cy5 | -0.0293 |
| GSM61798 | Cell Culture Exposure (1MAC Halo1) | Cy3; Cy5 | -0.2 |
| GSM61799 | Cell Culture Exposure (1MAC Halo2) | Cy3; Cy5 | -0.159 |
| GSM61800 | Cell Culture Exposure (1MAC Halo3) | Cy3; Cy5 | -0.103 |
| GSM61801 | Cell Culture Exposure (3MAC Halo1) | Cy3; Cy5 | -0.2 |
| GSM61802 | Cell Culture Exposure (3MAC Halo2) | Cy3; Cy5 | -0.166 |
| GSM61803 | Cell Culture Exposure (3MAC Halo3) | Cy3; Cy5 | -0.128 |
| GSM61804 | Cell Culture Exposure (3MAC ISO1) | Cy3; Cy5 | -0.0662 |
| GSM61805 | Cell Culture Exposure (3MAC ISO2) | Cy3; Cy5 | -0.165 |
| GSM61806 | Cell Culture Exposure (3MAC ISO3) | Cy3; Cy5 | 0.00597 |
| ID | GSE30365 |
| Title | Transcript Profiling of Arcuate Nucleus in Response to Electroacupuncture on Rats |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM753495 | 2Hz_HR_Arc1 rat | strain: Sprague-Dawley electroacupuncture: 2Hz responder: high;strain: Sprague-Dawley sample type: control | -0.1296 |
| GSM753496 | 2Hz_HR_Arc2 rat | strain: Sprague-Dawley electroacupuncture: 2Hz responder: high;strain: Sprague-Dawley sample type: control | -0.148 |
| GSM753497 | 2Hz_HR_Arc3 rat | strain: Sprague-Dawley electroacupuncture: 2Hz responder: high;strain: Sprague-Dawley sample type: control | -0.9701 |
| GSM753498 | 2Hz_NR_Arc1 rat | strain: Sprague-Dawley electroacupuncture: 2Hz responder: no; strain: Sprague-Dawley sample type: control | 0.3165 |
| GSM753499 | 2Hz_NR_Arc2 rat | strain: Sprague-Dawley electroacupuncture: 2Hz responder: no; strain: Sprague-Dawley sample type: control | -0.2654 |
| GSM753500 | 2Hz_NR_Arc3 rat | strain: Sprague-Dawley electroacupuncture: 2Hz responder: no; strain: Sprague-Dawley sample type: control | -0.2412 |
| GSM753501 | 100Hz_HR_Arc1 rat | strain: Sprague-Dawley electroacupuncture: 100Hz responder: high;strain: Sprague-Dawley sample type: control | 0.3846 |
| GSM753502 | 100Hz_HR_Arc2 rat | strain: Sprague-Dawley electroacupuncture: 100Hz responder: high;strain: Sprague-Dawley sample type: control | 0.0862 |
| GSM753503 | 100Hz_HR_Arc3 rat | strain: Sprague-Dawley electroacupuncture: 100Hz responder: high;strain: Sprague-Dawley sample type: control | 0.0755 |
| GSM753504 | 100Hz_NR_Arc1 rat | strain: Sprague-Dawley electroacupuncture: 100Hz responder: no;strain: Sprague-Dawley sample type: control | -0.5743 |
| GSM753505 | 100Hz_NR_Arc2 rat | strain: Sprague-Dawley electroacupuncture: 100Hz responder: no;strain: Sprague-Dawley sample type: control | -0.3796 |
| GSM753506 | 100Hz_NR_Arc3 rat | strain: Sprague-Dawley electroacupuncture: 100Hz responder: no;strain: Sprague-Dawley sample type: control | -0.86 |
| ID | GSE48025 |
| Title | Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch1) |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1165929 | RAT_NORA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 6.395482246 |
| GSM1165930 | RAT_NORA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 6.708170798 |
| GSM1165931 | RAT_RA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 6.360995237 |
| GSM1165932 | RAT_RA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 6.500092136 |
| GSM1165933 | RAT_NORA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 6.588347874 |
| GSM1165934 | RAT_NORA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 6.50068738 |
| GSM1165935 | RAT_AP_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 6.025975671 |
| GSM1165936 | RAT_AP_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 6.803847404 |
| GSM1165937 | RAT_MTX_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 6.786822723 |
| GSM1165938 | RAT_MTX_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 6.831386205 |
| GSM1165939 | RAT_ANE_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 6.997456543 |
| GSM1165940 | RAT_ANE_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 6.066601874 |
| GSM1165941 | RAT_PLA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 6.14821271 |
| GSM1165942 | RAT_PLA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 6.213271075 |
| GSM1165943 | RAT_NORA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 6.331833525 |
| GSM1165944 | RAT_NORA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 6.369890766 |
| GSM1165945 | RAT_AP_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 5.624022493 |
| GSM1165946 | RAT_AP_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 6.208907368 |
| GSM1165947 | RAT_MTX_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 6.219943915 |
| GSM1165948 | RAT_MTX_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 6.40520693 |
| GSM1165949 | RAT_ANE_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 6.217603305 |
| GSM1165950 | RAT_ANE_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 6.240475461 |
| GSM1165951 | RAT_PLA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 6.364238269 |
| GSM1165952 | RAT_PLA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 6.220324018 |
| ID | GSE53897 |
| Title | Genome-wide analysis of dorsal root ganglion (DRG) gene expression after morphine or oxycodone treatment |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1303240 | DRG RVM1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 9.897716 |
| GSM1303241 | DRG RVM2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 9.800263 |
| GSM1303242 | DRG RVM3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 10.106891 |
| GSM1303243 | DRG RVM7 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 9.64275 |
| GSM1303244 | DRG RVOx2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 9.72992 |
| GSM1303245 | DRG RVOx3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 9.994715 |
| GSM1303246 | DRG RVOx5 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 9.991364 |
| GSM1303247 | DRG RVOx7 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 9.895286 |
| GSM1303248 | DRG RVS4 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 9.860171 |
| GSM1303249 | DRG RVS5 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 9.696746 |
| GSM1303250 | DRG RVS6 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 9.948476 |
| GSM1303251 | DRG RVS7 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 9.97822 |
| GSM1303252 | DRG RSM1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 9.757965 |
| GSM1303253 | DRG RSM2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 10.089275 |
| GSM1303254 | DRG RSM4 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 9.989404 |
| GSM1303255 | DRG RSM5 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 9.900805 |
| GSM1303256 | DRG RSOx1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 9.700236 |
| GSM1303257 | DRG RSOx2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 9.952851 |
| GSM1303258 | DRG RSOx3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 9.799137 |
| GSM1303259 | DRG RSOx4 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 9.766605 |
| GSM1303260 | DRG RSS1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 9.654956 |
| GSM1303261 | DRG RSS2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 9.969477 |
| GSM1303262 | DRG RSS3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 10.021684 |
| GSM1303263 | DRG RSS6 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 10.020536 |
| ID | GSE55573 |
| Title | Using DNA microarray to screen intracellular signal pathways of hypoglycemic activity by electroacupuncture of Zusanli (ST36) acupoints in streptozotocin-induced rats with diabetes |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1339443 | Mock skeletal muscle | strain: Wistar age: 8-10 week-old gender: Male | 426.4694 |
| GSM1339444 | EA (electroacupuncture) skeletal muscle | strain: Wistar age: 8-10 week-old gender: Male | 325.0831 |
| ID | GSE58456 |
| Title | Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch 2) |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1693996 | Peripheral blood mononuclear cells from NORA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 24.9925472 |
| GSM1693997 | Peripheral blood mononuclear cells from NORA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 13.35302297 |
| GSM1693998 | Peripheral blood mononuclear cells from NORA before therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 29.23663101 |
| GSM1693999 | Peripheral blood mononuclear cells from RA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 25.58956115 |
| GSM1694000 | Peripheral blood mononuclear cells from RA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 29.36888795 |
| GSM1694001 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 19.18910175 |
| GSM1694002 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 34.9033274 |
| GSM1694003 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 22.22523321 |
| GSM1694004 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 23.90921129 |
| GSM1694005 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 27.94158586 |
| GSM1694006 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 19.55470398 |
| GSM1694007 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 30.64979071 |
| GSM1694008 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 19.84134163 |
| GSM1694009 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 28.70565086 |
| ID | GSE58460 |
| Title | Rheumatoid Arthritis Rat Model Treated with Acupuncture |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1165929 | RAT_NORA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 6.395482246 |
| GSM1165930 | RAT_NORA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 6.708170798 |
| GSM1165931 | RAT_RA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 6.360995237 |
| GSM1165932 | RAT_RA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 6.500092136 |
| GSM1165933 | RAT_NORA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 6.588347874 |
| GSM1165934 | RAT_NORA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 6.50068738 |
| GSM1165935 | RAT_AP_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 6.025975671 |
| GSM1165936 | RAT_AP_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 6.803847404 |
| GSM1165937 | RAT_MTX_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 6.786822723 |
| GSM1165938 | RAT_MTX_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 6.831386205 |
| GSM1165939 | RAT_ANE_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 6.997456543 |
| GSM1165940 | RAT_ANE_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 6.066601874 |
| GSM1165941 | RAT_PLA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 6.14821271 |
| GSM1165942 | RAT_PLA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 6.213271075 |
| GSM1165943 | RAT_NORA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 6.331833525 |
| GSM1165944 | RAT_NORA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 6.369890766 |
| GSM1165945 | RAT_AP_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 5.624022493 |
| GSM1165946 | RAT_AP_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 6.208907368 |
| GSM1165947 | RAT_MTX_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 6.219943915 |
| GSM1165948 | RAT_MTX_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 6.40520693 |
| GSM1165949 | RAT_ANE_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 6.217603305 |
| GSM1165950 | RAT_ANE_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 6.240475461 |
| GSM1165951 | RAT_PLA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 6.364238269 |
| GSM1165952 | RAT_PLA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 6.220324018 |
| GSM1412003 | RAT_NORA_T0_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412004 | RAT_NORA_T0_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412005 | RAT_RA_T0_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412006 | RAT_RA_T0_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412007 | RAT_NORA_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412008 | RAT_NORA_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412009 | RAT_AP_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412010 | RAT_AP_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412011 | RAT_MTX_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412012 | RAT_MTX_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412013 | RAT_ANE_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412014 | RAT_ANE_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412015 | RAT_PLA_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412016 | RAT_PLA_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412017 | RAT_NORA_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412018 | RAT_NORA_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412019 | RAT_AP_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412020 | RAT_AP_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412021 | RAT_MTX_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412022 | RAT_MTX_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412023 | RAT_ANE_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412024 | RAT_ANE_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412025 | RAT_PLA_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412026 | RAT_PLA_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412027 | RAT_RA_T0_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412028 | RAT_RA_T0_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412029 | RAT_AP_1h_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412030 | RAT_AP_1h_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412031 | RAT_PLA_1h_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412032 | RAT_PLA_1h_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412033 | RAT_AP_34d_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412034 | RAT_AP_34d_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412035 | RAT_PLA_34d_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412036 | RAT_PLA_34d_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1693996 | Peripheral blood mononuclear cells from NORA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therap | 24.9925472 |
| GSM1693997 | Peripheral blood mononuclear cells from NORA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 13.35302297 |
| GSM1693998 | Peripheral blood mononuclear cells from NORA before therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 29.23663101 |
| GSM1693999 | Peripheral blood mononuclear cells from RA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 25.58956115 |
| GSM1694000 | Peripheral blood mononuclear cells from RA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 29.36888795 |
| GSM1694001 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 19.18910175 |
| GSM1694002 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therap | 34.9033274 |
| GSM1694003 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 22.22523321 |
| GSM1694004 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 23.90921129 |
| GSM1694005 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 27.94158586 |
| GSM1694006 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 19.55470398 |
| GSM1694007 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 30.64979071 |
| GSM1694008 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 19.84134163 |
| GSM1694009 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 28.70565086 |
| ID | GSE58803 |
| Title | Transcript Profiling of Periaqueductal Gray in Response to Electroacupuncture on Rats |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1419812 | 2Hz_HR_1h_PAG1 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.66614642 |
| GSM1419813 | 2Hz_HR_1h_PAG2 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.3693022 |
| GSM1419814 | 2Hz_HR_1h_PAG3 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 1h; strain: Sprague-Dawley treatment: control tissue: PAG | -0.584227598 |
| GSM1419815 | 2Hz_HR_1h_PAG4 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.476364745 |
| GSM1419816 | 2Hz_HR_1h_PAG5 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.876254245 |
| GSM1419817 | 2Hz_NR_1h_PAG1 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: low responder(NR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.782708803 |
| GSM1419818 | 2Hz_NR_1h_PAG2 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: low responder(NR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.315987531 |
| GSM1419819 | 2Hz_NR_1h_PAG3 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: low responder(NR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.53048408 |
| GSM1419820 | 2Hz_NR_1h_PAG4 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: low responder(NR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.80534334 |
| GSM1419821 | 100Hz_HR_1h_PAG1 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.491694854 |
| GSM1419822 | 100Hz_HR_1h_PAG2 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.86391158 |
| GSM1419823 | 100Hz_HR_1h_PAG3 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.907379087 |
| GSM1419824 | 100Hz_HR_1h_PAG4 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | -2.246984675 |
| GSM1419825 | 100Hz_HR_1h_PAG5 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | -1.27064061 |
| GSM1419826 | 100Hz_NR_1h_PAG1 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 1h; strain: Sprague-Dawley treatment: control tissue: PAG | -2.531953856 |
| GSM1419827 | 100Hz_NR_1h_PAG2 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 1h; strain: Sprague-Dawley treatment: control tissue: PAG | -1.173491335 |
| GSM1419828 | 100Hz_NR_1h_PAG3 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 1h; strain: Sprague-Dawley treatment: control tissue: PAG | -0.497049685 |
| GSM1419829 | 100Hz_NR_1h_PAG4 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | -2.244790005 |
| GSM1419830 | 100Hz_NR_1h_PAG5 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | -1.131632106 |
| GSM1419831 | 2Hz_HR_24h_PAG1 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.185009409 |
| GSM1419832 | 2Hz_HR_24h_PAG2 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.745486913 |
| GSM1419833 | 2Hz_HR_24h_PAG3 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 24h; strain: Sprague-Dawley treatment: control tissue: PAG | -0.301196214 |
| GSM1419834 | 2Hz_HR_24h_PAG4 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.658902355 |
| GSM1419835 | 2Hz_HR_24h_PAG5 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | 0.134578824 |
| GSM1419836 | 2Hz_NR_24h_PAG1 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.804511942 |
| GSM1419837 | 2Hz_NR_24h_PAG2 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.023503405 |
| GSM1419838 | 2Hz_NR_24h_PAG3 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.964700563 |
| GSM1419839 | 2Hz_NR_24h_PAG4 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.082703157 |
| GSM1419840 | 2Hz_NR_24h_PAG5 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.304984004 |
| GSM1419841 | 100Hz_HR_24h_PAG1 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.356655902 |
| GSM1419842 | 100Hz_HR_24h_PAG2 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.567821936 |
| GSM1419843 | 100Hz_HR_24h_PAG3 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.182572372 |
| GSM1419844 | 100Hz_HR_24h_PAG4 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.357386531 |
| GSM1419845 | 100Hz_HR_24h_PAG5 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.173747995 |
| GSM1419846 | 100Hz_NR_24h_PAG1 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.276249349 |
| GSM1419847 | 100Hz_NR_24h_PAG2 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.447460045 |
| GSM1419848 | 100Hz_NR_24h_PAG3 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.216408234 |
| GSM1419849 | 100Hz_NR_24h_PAG4 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.366079229 |
| GSM1419850 | 100Hz_NR_24h_PAG5 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -1.019846245 |
| ID | GSE8911 |
| Title | Skeletal muscle after fine needle stimulation |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM225891 | Skeletal muscle sample from fine needle-stimulated hindlimb | Strain: Lewis, Gender: Male, Body Weight: 275g, Tissue: Skeletal muscle sample from fine nnedle-stimulated hindlimb | 37.4447 |
| GSM225892 | Skeletal muscle sample from control hindlimb | Strain: Lewis, Gender: Male, Body weight: 275g, Tissue: skeletal muscle sample from non fine needle-stimulated hindlimb | 19.73 |
